摘要
目的探讨多期增强CT对富血供肝内胆管癌与肝细胞癌的鉴别诊断价值。方法选择208例原发性肝扫描,观察多期CT扫描对富血供肝内胆管癌与肝细胞癌的鉴别诊断价值。结果 208例患者最终确诊为肝内胆管癌29例(13.94%),肝细胞肝癌179例(86.06%)。多因素logistic分析显示,甲胎蛋白≤20 ng/ml、E-U E-U值诊断肝内胆管癌曲线下面积为0.84(95%CI 0.75～0.93),最佳截断值为49 Hu。结论 E-U值对鉴别肝内胆管癌和肝细胞癌具有一定临床价值。
Objective To explore the value of multi-phase contrast-enhanced CT in differential diagnosis of hypervascular intrahepatic cholangiocarcinoma and hepatocellular carcinoma.Metheds Totally 208 patients with primary hepatocellular carcinoma were selected as the study subjects,and all patients received multi-phase enhanced CT scan before operation.The value of multi-phase CT scan in differential diagnosis of hypervascular intrahepatic cholangiocarcinoma and hepatocellular carcinoma was observed. Results Of 208 patients with primary hepatocellular carcinoma,29(13.94%)cases were intrahepatic cholangiocarcinoma,and 179(86.06%)cases were hepatocellular carcinoma.The multivariate logistic analysis showed that the level of AFP less than or equal to 20 ng/ml and E-U value greater than 49 HU were risk factors for intrahepatic cholangiocarcinoma(OR = 4.21,1.34,P<0.05).The ROC showed that the area under the curve of E-U value for diagnosis of intrahepatic cholangiocarcinoma was 0.84(95% CI 0.75~0.93),and the cutoff value was 49 Hu. Conclusion The E-U value has certain clinical value in differentiating intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
作者
李烽
LI Feng(Department of Radiology,Li Huili Hospital,Ningbo Medical Center,Ningbo 315040,China)
出处
《全科医学临床与教育》
2019年第3期236-239,共4页
Clinical Education of General Practice
关键词
原发性肝癌
肝细胞癌
肝内胆管癌
多期增强CT
primary hepatocellular carcinoma
hepatocellular carcinoma
intrahepatic cholangiocarcinoma
multiphase enhanced CT
